Downregulation of CSF-1 in GBM cells by fibulin-3 inhibition did not lead to increased IGF-1 in the tumor (Supplementary Fig. S7), possibly preventing this tumor-salvage pathway. This evidence concerns the gene IGF1 and neoplasm.